Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-22

Clinical Trial Update: Monitoring Response to Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Using High-speed MR Spectroscopic Imaging

View source ↗

Summary

Clinical trial update on an active-not-recruiting study evaluating high-speed MR spectroscopic imaging to monitor response to neoadjuvant chemotherapy in HER2-n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: New Mexico Cancer Research Alliance | Conditions: HER2 Negative Breast Cancer | Status: ACTIVE_NOT_RECRUITING